RE:Bought deal RAISES questions. Why now?the insider your referring to that sold was a director exercising stock options that were expiring. They only had enough cash for this trial. If the trial is successful they have fast track designation from the FDA and will immediately start a trial for drug approval. The offering is with close tied underwriters and insiders
“Certain insiders of the Company, led by an entity associated with PFP Biosciences, the largest inside shareholder who invested US$15 million in 2022, as well as a majority of the Company's executives and board members are expected to participate in the Offering.”
Make what you want of it. Best of luck
Cheers